A handful of employees at a family owned drug research company at East Tennessee State University’s Valleybrook Campus are poised to make a big impact on the pharmaceutical industry.
Eric Latham, founder and CEO of Intellectual Property Executives Inc., said his family business has been the development of new drugs to treat a range of ailments and diseases, including breast cancer, Alzheimer’s disease and Parkinson’s disease.
None of these drugs in the company’s pipeline have been to market yet, but recently an IPE drug to treat hypothyroidism was submitted for what is known as phase II testing.
Read the full story on the Johnson City Press website.